Mouse Model Shows that Cancer Drug May Reverse Alzheimer’s

A study conducted at the University of Pittsburgh Graduate School of Public Health has found that bexarotene, a drug commonly used to fight cancer, makes up for the cognitive deficits in mice with gene mutations linked to Alzheimer’s disease in humans. Researchers believe that this finding opens the door for the use of bexarotene in Alzheimer’s treatment. Click here to read the full story.